|
1
|
Rojas LBA and Gomes MB: Metformin: An old
but still the best treatment for type 2 diabetes. Diabetol Metab
Syndr. 5(6)2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ceriello A and Colagiuri S: IDF global
clinical practice recommendations for managing type 2
diabetes-2025. Diabetes Res Clin Pract. 222(112152)2025.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mbara KC, Mato PE, Driver C, Nzuza S,
Mkhombo NT, Gcwensa SK, Mcobothi EN and Owira PM: Metformin turns
62 in pharmacotherapy: Emergence of non-glycaemic effects and
potential novel therapeutic applications. Eur J Pharmacol.
898(173934)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mostafa DK, Nayel OA, Abdulmalek S,
Abdelbary AA and Ismail CA: Modulation of autophagy, apoptosis and
oxidative stress: A clue for repurposing metformin in photoaging.
Inflammopharmacology. 30:2521–2535. 2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
AboAlsoud ES, Eldahshan RM, Mohammed H and
Elsaie ML: Safety and efficacy of topical metformin 30% cream
versus triple combination cream (Kligman's formula) in treating
melasma: A randomized controlled study. J Cosmet Dermatol.
21:2508–2515. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang J, Shimozaki K, Hattori S, Pastukh
V, Maloney D, Hogan MV and Wang JHC: Metformin lotion promotes
scarless skin tissue formation through AMPK activation, TGF-β1
inhibition, and reduced myofibroblast numbers. PLoS One.
19(e0311147)2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shojaeian A: Harnessing the power of
non-diabetic benefits of metformin derived from galega officinalis:
Focus on wound healing. J Wound Manag Res. 20:212–218. 2024.
|
|
8
|
Tawfeek HM, Abou-Taleb DAE, Badary DM,
Ibrahim M and Abdellatif AAH: Pharmaceutical, clinical, and
immunohistochemical studies of metformin hydrochloride topical
hydrogel for wound healing application. Arch Dermatol Res.
312:113–121. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cam ME, Crabbe-Mann M, Alenezi H,
Hazar-Yavuzc AN, Ertasc B, Ekentoke C, Ozcanf GS, Topalc F, Gulerb
E, Yazir Y, et al: The comparison of glybenclamide and
metformin-loaded bacterial cellulose/gelatin nanofibres produced by
a portable electrohydrodynamic gun for diabetic wound healing. Eur
Polym J. 134(109844)2020.
|
|
10
|
Tombulturk FK, Soydas T and
Kanigur-Sultuybek G: Topical metformin accelerates wound healing by
promoting collagen synthesis and inhibiting apoptosis in a diabetic
wound model. Int Wound J. 21(e14345)2024.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tombulturk FK, Todurga-Seven ZG,
Huseyinbas O, Ozyazgan S, Ulutin T and Kanigur-Sultuybek G: Topical
application of metformin accelerates cutaneous wound healing in
streptozotocin-induced diabetic rats. Mol Biol Rep. 49:73–83.
2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
El-Komy MHM, Abdo NMK, Shamma RN and
Bedair NI: Topical metformin 30% gel in the treatment of acne
vulgaris in women, a split face, placebo-controlled study. Exp
Dermatol. 32:1663–1673. 2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xiong S, Liu W, Song Y, Du J, Wang T,
Zhang Y, Huang Z, He Q, Dong C, Yu Z and Ma X: Metformin promotes
mechanical stretch-induced skin regeneration by improving the
proliferative activity of skin-derived stem cells. Front Med
(Lausanne). 9(813917)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Channakeshavaiah B and Chandrappa NKA:
Topical metformin in the treatment of melasma: A preliminary
clinical trial. J Cosmet Dermatol. 19:1161–1164. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xiao T, Chen Y, Song C, Xu S, Lin S, Li M,
Chen X and Gu H: Possible treatment for UVB-induced skin injury:
Anti-inflammatory and cytoprotective role of metformin in
UVB-irradiated keratinocytes. J Dermatol Sci. 102:25–35.
2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mongkhon P, Ruengorn C, Awiphan R, Phosuya
C, Ruanta Y, Thavorn K, Jamjanya S, Chuamanochan M and Nochaiwong
S: Efficacy and safety of metformin for melasma treatment: A
systematic review and meta-analysis. Front Pharmacol.
14(1281050)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lehraiki A, Abbe P, Cerezo M, Rouaud F,
Regazzetti C, Chignon-Sicard B, Passeron T, Bertolotto C, Ballotti
R and Rocchi S: Inhibition of melanogenesis by the antidiabetic
metformin. J Invest Dermatol. 134:2589–2597. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu X, Sun X, Liu Y, Wang W, Yang H, Ge Y,
Yang Y, Chen X and Lin T: Metformin inhibits melanin synthesis and
melanosome transfer through the cAMP pathway. Sci Rep.
15(11442)2025.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cui B, Liu Q, Tong L and Feng X: The
effects of the metformin on inhibition of UVA-induced expression of
MMPs and COL-I in human skin fibroblasts. Eur J Inflamm.
17:doi.org/10.1177/2058739219876423. 2019.
|
|
20
|
Mousa IA, Hammady TM, Gad S, Zaitone SA,
El-Sherbiny M and Sayed OM: Formulation and characterization of
metformin-loaded ethosomes for topical application to
experimentally induced skin cancer in mice. Pharmaceuticals
(Basel). 15(657)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yu X, Zhou W, Wang H, Lu S, Jin Y and Fu
J: Transdermal metformin hydrochloride-loaded cubic phases: In
silico formulation optimization, preparation, properties, and
application for local treatment of melanoma. Drug Deliv.
26:376–383. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen Q, Zhang H, Yang Y, Zhang S, Wang J,
Zhang D and Yu H: Metformin attenuates UVA-induced skin photoaging
by suppressing mitophagy and the PI3K/AKT/mTOR pathway. Int J Mol
Sci. 23(6960)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ali Mapar M, Hemmati AA and Namdari G:
Comparing the efficacy of topical metformin and placebo in the
treatment of melasma: A randomized, double-blind, clinical trial. J
Pharm Res Int. 30:1–8. 2019.
|
|
24
|
Yu X, Mao W, Zhai Y, Tong C, Liu M, Ma L,
Yu X and Li S: Anti-tumor activity of metformin: From metabolic and
epigenetic perspectives. Oncotarget. 8:5619–5628. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Saxton RA and Sabatini DM: mTOR signaling
in growth, metabolism, and disease. Cell. 168:960–976.
2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhao S, Wen H, Wang B, Xiong Q, Li L and
Cheng A: p53: A player in the tumor microenvironment. Oncol Res.
33:795–810. 2025.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yam CQX, Lim HH and Surana U: DNA damage
checkpoint execution and the rules of its disengagement. Front Cell
Dev Biol. 10(1020643)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhong X, Deng Y, Yang H, Du X, Liu P and
Du Y: Role of autophagy in skin photoaging: A narrative review.
Medicine (Baltimore). 103(e37178)2024.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Vikram A, Patel SK, Singh A, Pathania D,
Ray RS, Upadhyay AK and Dwivedi A: Natural autophagy activators: A
promising strategy for combating photoaging. Phytomedicine.
132(155508)2024.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhao P, Sui B, Liu N, Lv YJ, Zheng CX, Lu
YB, Huang WT, Zhou CH, Chen J, Pang DL, et al: Anti-aging
pharmacology in cutaneous wound healing: Effects of metformin,
resveratrol, and rapamycin by local application. Aging Cell.
16:1083–1093. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tombulturk FK, Soydas T and
Kanigur-Sultuybek G: Metformin as a modulator of autophagy and
hypoxia responses in the enhancement of wound healing in diabetic
rats. Inflammation. 48:1391–1402. 2024.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Qing L, Fu J, Wu P, Zhou Z, Yu F and Tang
J: Metformin induces the M2 macrophage polarization to accelerate
the wound healing via regulating AMPK/mTOR/NLRP3 inflammasome
singling pathway. Am J Transl Res. 11:655–668. 2019.PubMed/NCBI
|
|
33
|
Cam ME, Ertas B, Alenezi H, Hazar-Yavuz
AN, Cesur S, Ozcan GS, Ekentok C, Guler E, Katsakouli C, Demirbas
Z, et al: Accelerated diabetic wound healing by topical application
of combination oral antidiabetic agents-loaded nanofibrous
scaffolds: An in vitro and in vivo evaluation study. Mater Sci Eng
C. 119(111586)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cho M, Woo YR, Cho SH, Lee JD and Kim HS:
Metformin: A potential treatment for acne, hidradenitis suppurativa
and rosacea. Acta Derm Venereol. 103(adv18392)2023.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Liu Y, Yang F, Ma W and Sun Q: Metformin
inhibits proliferation and proinflammatory cytokines of human
keratinocytes in vitro via mTOR-signaling pathway. Pharm Biol.
54:1173–1178. 2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kokhabi P, Dadkhahfar S and Robati RM:
Topical metformin as a novel therapy for alopecia areata due to its
immunologic effects. Med Hypotheses. 179(111155)2023.
|
|
37
|
Solano F, Briganti S, Picardo M and Ghanem
G: Hypopigmenting agents: An updated review on biological, chemical
and clinical aspects. Pigment Cell Res. 19:550–571. 2006.PubMed/NCBI View Article : Google Scholar
|
